Literature DB >> 2905265

Secretion of cyclolysin, the calmodulin-sensitive adenylate cyclase-haemolysin bifunctional protein of Bordetella pertussis.

P Glaser1, H Sakamoto, J Bellalou, A Ullmann, A Danchin.   

Abstract

The calmodulin-sensitive adenylate cyclase of Bordetella pertussis, a 45 kd secreted protein, is synthesized as a 1706 amino acid precursor. We have shown that this precursor is a bifunctional protein, carrying both adenylate cyclase and haemolytic activities. The 1250 carboxy-terminal amino acids of the precursor showed 25% similarity with Escherichia coli alpha-haemolysin (HlyA) and 22% similarity with Pasteurella haemolytica leucotoxin. Three open reading frames were identified downstream from the cyaA gene: cyaB, cyaD and cyaE, coding for polypeptides of 712, 440 and 474 amino acid residues, respectively. As for E. coli alpha-haemolysin, secretion of B.pertussis adenylate cyclase and haemolysin requires the expression of additional genes. The gene products of cyaB and cyaD are highly similar to HlyB and HlyD, known to be necessary for the transport of HlyA across the cell envelope and for its release into the external medium. Complementation and functional studies indicate that the B.pertussis adenylate cyclase-haemolysin bifunctional protein is secreted by a mechanism similar to that described for E.coli alpha-haemolysin, requiring, in addition to the cyaB and cyaD gene products, the presence of a third gene product specified by the cyaE gene.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2905265      PMCID: PMC455007          DOI: 10.1002/j.1460-2075.1988.tb03288.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  37 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  A simple chemically defined medium for the production of phase I Bordetella pertussis.

Authors:  D W Stainer; M J Scholte
Journal:  J Gen Microbiol       Date:  1970-10

3.  Construction of broad-host-range cosmid cloning vectors: identification of genes necessary for growth of Methylobacterium organophilum on methanol.

Authors:  L N Allen; R S Hanson
Journal:  J Bacteriol       Date:  1985-03       Impact factor: 3.490

4.  Chemical synthesis and expression of a calmodulin gene designed for site-specific mutagenesis.

Authors:  D M Roberts; R Crea; M Malecha; G Alvarado-Urbina; R H Chiarello; D M Watterson
Journal:  Biochemistry       Date:  1985-09-10       Impact factor: 3.162

5.  Functional genetic expression of eukaryotic DNA in Escherichia coli.

Authors:  K Struhl; J R Cameron; R W Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

6.  Nucleotide sequence of an Escherichia coli chromosomal hemolysin.

Authors:  T Felmlee; S Pellett; R A Welch
Journal:  J Bacteriol       Date:  1985-07       Impact factor: 3.490

7.  Characterisation of HlyC and mechanism of activation and secretion of haemolysin from E. coli 2001.

Authors:  J M Nicaud; N Mackman; L Gray; I B Holland
Journal:  FEBS Lett       Date:  1985-08-05       Impact factor: 4.124

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Improvement of the dideoxy chain termination method of DNA sequencing by use of deoxy-7-deazaguanosine triphosphate in place of dGTP.

Authors:  S Mizusawa; S Nishimura; F Seela
Journal:  Nucleic Acids Res       Date:  1986-02-11       Impact factor: 16.971

10.  Cloning and nucleotide sequence of the aroA gene of Bordetella pertussis.

Authors:  D J Maskell; P Morrissey; G Dougan
Journal:  J Bacteriol       Date:  1988-06       Impact factor: 3.490

View more
  165 in total

Review 1.  Chunnel vision. Export and efflux through bacterial channel-tunnels.

Authors:  C Andersen; C Hughes; V Koronakis
Journal:  EMBO Rep       Date:  2000-10       Impact factor: 8.807

2.  Epitope mapping of monoclonal antibodies against Bordetella pertussis adenylate cyclase toxin.

Authors:  S J Lee; M C Gray; L Guo; P Sebo; E L Hewlett
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  Secretion of RTX leukotoxin by Actinobacillus actinomycetemcomitans.

Authors:  S C Kachlany; D H Fine; D H Figurski
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

4.  Role of CD11b/CD18 in the process of intoxication by the adenylate cyclase toxin of Bordetella pertussis.

Authors:  Joshua C Eby; Mary C Gray; Annabelle R Mangan; Gina M Donato; Erik L Hewlett
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

5.  Yop fusions to tightly folded protein domains and their effects on Yersinia enterocolitica type III secretion.

Authors:  Vincent T Lee; Olaf Schneewind
Journal:  J Bacteriol       Date:  2002-07       Impact factor: 3.490

6.  Finding errors in DNA sequences.

Authors:  J Posfai; R J Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

Review 7.  Cyclic AMP in prokaryotes.

Authors:  J L Botsford; J G Harman
Journal:  Microbiol Rev       Date:  1992-03

8.  Characterization of adenylate cyclase-hemolysin gene duplication in a Bordetella pertussis isolate.

Authors:  Karine Dalet; Christian Weber; Laurent Guillemot; Elisabeth Njamkepo; Nicole Guiso
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

9.  Identification of a region that assists membrane insertion and translocation of the catalytic domain of Bordetella pertussis CyaA toxin.

Authors:  Johanna C Karst; Robert Barker; Usha Devi; Marcus J Swann; Marilyne Davi; Stephen J Roser; Daniel Ladant; Alexandre Chenal
Journal:  J Biol Chem       Date:  2012-01-12       Impact factor: 5.157

10.  Regulation of leukotoxin in leukotoxic and nonleukotoxic strains of Actinobacillus actinomycetemcomitans.

Authors:  J Spitznagel; E Kraig; D Kolodrubetz
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.